These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11291380)

  • 1. Risk of infection from needle reuse at a phlebotomy center.
    Porco TC; Aragón TJ; Fernyak SE; Cody SH; Vugia DJ; Katz MH; Bangsberg DR
    Am J Public Health; 2001 Apr; 91(4):636-8. PubMed ID: 11291380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Model-based estimates of the risk of human immunodeficiency virus and hepatitis B virus transmission through unsafe injections.
    Aylward B; Kane M; McNair-Scott R; Hu DJ; Hu DH
    Int J Epidemiol; 1995 Apr; 24(2):446-52. PubMed ID: 7635609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenge of judge authorized in HIV-exposure case.
    AIDS Policy Law; 2007 Apr; 22(7):6. PubMed ID: 17491121
    [No Abstract]   [Full Text] [Related]  

  • 4. Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000.
    Chiavetta JA; Escobar M; Newman A; He Y; Driezen P; Deeks S; Hone DE; O'Brien SF; Sher G
    CMAJ; 2003 Oct; 169(8):767-73. PubMed ID: 14557314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population risk of syringe reuse: estimating the probability of transmitting bloodborne disease.
    Sikora C; Chandran AU; Joffe AM; Johnson D; Johnson M
    Infect Control Hosp Epidemiol; 2010 Jul; 31(7):748-54. PubMed ID: 20509761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transmission of hepatitis B and C viruses in outpatient settings--New York, Oklahoma, and Nebraska, 2000-2002.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2003 Sep; 52(38):901-6. PubMed ID: 14508437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid assessment of injection practices in Cambodia, 2002.
    Vong S; Perz JF; Sok S; Som S; Goldstein S; Hutin Y; Tulloch J
    BMC Public Health; 2005 Jun; 5():56. PubMed ID: 15929800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bloodborne pathogen exposures in a developmental center: 1993-2000.
    Lohiya GS; Tan-Figueroa L; Lohiya S
    Infect Control Hosp Epidemiol; 2001 Jun; 22(6):382-5. PubMed ID: 11519919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transmission of hepatitis B, hepatitis C and human immunodeficiency viruses through unsafe injections in the developing world: model-based regional estimates.
    Kane A; Lloyd J; Zaffran M; Simonsen L; Kane M
    Bull World Health Organ; 1999; 77(10):801-7. PubMed ID: 10593027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probability of viremia with HBV, HCV, HIV, and HTLV among tissue donors in the United States.
    Zou S; Dodd RY; Stramer SL; Strong DM;
    N Engl J Med; 2004 Aug; 351(8):751-9. PubMed ID: 15317888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of infections associated with improperly reprocessed transrectal ultrasound-guided prostate biopsy equipment.
    Lessa F; Tak S; Devader SR; Goswami R; Anderson M; Williams I; Gensheimer KF; Srinivasan A
    Infect Control Hosp Epidemiol; 2008 Apr; 29(4):289-93. PubMed ID: 18462138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [HIV, HBV, or HCV transmission from infected health care workers to patients].
    Puro V; Scognamiglio P; Ippolito G
    Med Lav; 2003; 94(6):556-68. PubMed ID: 14768247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cost-effectiveness of policies for the safe and appropriate use of injection in healthcare settings.
    Dziekan G; Chisholm D; Johns B; Rovira J; Hutin YJ
    Bull World Health Organ; 2003; 81(4):277-85. PubMed ID: 12764494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unsafe injections in the developing world and transmission of bloodborne pathogens: a review.
    Simonsen L; Kane A; Lloyd J; Zaffran M; Kane M
    Bull World Health Organ; 1999; 77(10):789-800. PubMed ID: 10593026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
    Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
    Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
    Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
    Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus.
    Seed CR; Kiely P; Keller AJ
    Intern Med J; 2005 Oct; 35(10):592-8. PubMed ID: 16207258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A large nosocomial outbreak of hepatitis C and hepatitis B among patients receiving pain remediation treatments.
    Comstock RD; Mallonee S; Fox JL; Moolenaar RL; Vogt TM; Perz JF; Bell BP; Crutcher JM
    Infect Control Hosp Epidemiol; 2004 Jul; 25(7):576-83. PubMed ID: 15301030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Needle sticks and adverse outcomes in office-based allergy practices.
    Kanter LJ; Siegel C
    Ann Allergy Asthma Immunol; 2003 Apr; 90(4):389-92. PubMed ID: 12722959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. History of syringe sharing in prison and risk of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection among injecting drug users in Berlin.
    Stark K; Bienzle U; Vonk R; Guggenmoos-Holzmann I
    Int J Epidemiol; 1997 Dec; 26(6):1359-66. PubMed ID: 9447418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.